Maesaka, F.; Kuwada, M.; Horii, S.; Kishi, S.; Fujiwara-Tani, R.; Mori, S.; Fujii, K.; Mori, T.; Ohmori, H.; Owari, T.;
et al. Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. Int. J. Mol. Sci. 2022, 23, 6516.
https://doi.org/10.3390/ijms23126516
AMA Style
Maesaka F, Kuwada M, Horii S, Kishi S, Fujiwara-Tani R, Mori S, Fujii K, Mori T, Ohmori H, Owari T,
et al. Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. International Journal of Molecular Sciences. 2022; 23(12):6516.
https://doi.org/10.3390/ijms23126516
Chicago/Turabian Style
Maesaka, Fumisato, Masaomi Kuwada, Shohei Horii, Shingo Kishi, Rina Fujiwara-Tani, Shiori Mori, Kiyomu Fujii, Takuya Mori, Hitoshi Ohmori, Takuya Owari,
and et al. 2022. "Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer" International Journal of Molecular Sciences 23, no. 12: 6516.
https://doi.org/10.3390/ijms23126516
APA Style
Maesaka, F., Kuwada, M., Horii, S., Kishi, S., Fujiwara-Tani, R., Mori, S., Fujii, K., Mori, T., Ohmori, H., Owari, T., Miyake, M., Nakai, Y., Tanaka, N., Bhawal, U. K., Luo, Y., Kondoh, M., Fujimoto, K., & Kuniyasu, H.
(2022). Hypomethylation of CLDN4 Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer. International Journal of Molecular Sciences, 23(12), 6516.
https://doi.org/10.3390/ijms23126516
